Market Cap 31.86B
Revenue (ttm) 6.95B
Net Income (ttm) 1.30B
EPS (ttm) N/A
PE Ratio 19.86
Forward PE 18.81
Profit Margin 18.75%
Debt to Equity Ratio 0.44
Volume 1,036,286
Avg Vol 2,295,820
Day's Range N/A - N/A
Shares Out 282.60M
Stochastic %K 17%
Beta 1.31
Analysts Strong Sell
Price Target $165.47

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufact...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 800 227 9770
Address:
5301 Stevens Creek Boulevard, Santa Clara, United States
SuperGreenToday
SuperGreenToday Mar. 17 at 6:32 PM
$A Share Price: $113.65 Contract Selected: Jun 18, 2026 $115 Calls Buy Zone: $4.67 – $5.78 Target Zone: $7.94 – $9.71 Potential Upside: 60% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 2:12 PM
$A 🎯 STOCK NEWS ALERT 💵 Price: $113.63 (+1.91%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Contractor Connection and Helixco partner to enhance the commercial managed repair program with real-time transparency and time and materials validation. The partnership strengthens Contractor… 📎 https://stocknews.live/news/A/crawford-contractor-connection-announces-62531.html
0 · Reply
CasperPuff
CasperPuff Mar. 12 at 5:06 PM
$A just got in
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 3:08 PM
Agilent Technologies announced it will acquire privately held clinical pathology firm Biocare Medical for $950 million in cash. The deal strengthens Agilent’s position in immunohistochemistry, a cancer diagnostic technique that uses antibodies to detect abnormal cells. Biocare Medical offers integrated tissue-diagnostics tools used for cancer and infectious disease testing, with government and military laboratories among its customers. Agilent said the acquisition should boost revenue growth and profit margins in the first year while increasing its share of consumables and services sales. The transaction is expected to close by the end of the fourth quarter of 2026, subject to regulatory approval. $A
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 9 at 12:19 PM
$A (+0.0% pre) Agilent to acquire Biocare Medical in $950 million all-cash deal https://ooc.bz/l/95944
0 · Reply
mikesterz7
mikesterz7 Mar. 9 at 12:12 PM
$A Agilent expects the deal to boost revenue growth and margins in the first year, with the transaction projected to add to earnings per share about 12 months after closing.
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 9 at 8:20 AM
Agilent Stock Slips Premarket: $950M Biocare Buyout Fails To Lift Investor Sentiment After Q1 Miss $A https://stocktwits.com/news/equity/markets/agilent-stock-slips-premarket-biocare-buyout-fails-to-lift-sentiment-after-q1-earnings-miss/cZdVgmGRII5
0 · Reply
StockNews_Live
StockNews_Live Mar. 9 at 7:00 AM
$A Agilent Technologies Inc. announced the acquisition of Biocare Medical, a global leader in clinical pathology, for $950 million. The acquisition is expected to be accretive to Agilent's top-line growt…
0 · Reply
Arcides
Arcides Mar. 8 at 8:49 PM
$A Will this come to 96 area again?
0 · Reply
richardxkxkTwits
richardxkxkTwits Mar. 8 at 12:37 PM
$A lol
0 · Reply
Latest News on A
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript

Feb 25, 2026, 11:37 PM EST - 21 days ago

Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript


Agilent Announces Cash Dividend of 25.5 Cents per Share

Feb 11, 2026, 4:15 PM EST - 5 weeks ago

Agilent Announces Cash Dividend of 25.5 Cents per Share


Active Managers Add 25% to Short-Term Bond Returns

Feb 6, 2026, 9:12 AM EST - 5 weeks ago

Active Managers Add 25% to Short-Term Bond Returns


Agilent Technologies: Steady As She Goes

Nov 26, 2025, 9:16 AM EST - 4 months ago

Agilent Technologies: Steady As She Goes


Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 4 months ago

Top small-cap plays for 2026

COHR DG EW TXT VLO


Agilent Technologies, Inc. (A) Q4 2025 Earnings Call Transcript

Nov 25, 2025, 3:43 AM EST - 4 months ago

Agilent Technologies, Inc. (A) Q4 2025 Earnings Call Transcript


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 4 months ago

Josh Brown's ‘best stocks in the market': Health Care

LLY MTD TMO XLV


Agilent Announces Cash Dividend of 25.5 Cents Per Share

Nov 19, 2025, 4:15 PM EST - 4 months ago

Agilent Announces Cash Dividend of 25.5 Cents Per Share


Agilent Names Adam S. Elinoff as Chief Financial Officer

Oct 27, 2025, 4:15 PM EDT - 5 months ago

Agilent Names Adam S. Elinoff as Chief Financial Officer


Agilent Announces Cash Dividend of 24.8 Cents per Share

Sep 17, 2025, 4:05 PM EDT - 6 months ago

Agilent Announces Cash Dividend of 24.8 Cents per Share


SuperGreenToday
SuperGreenToday Mar. 17 at 6:32 PM
$A Share Price: $113.65 Contract Selected: Jun 18, 2026 $115 Calls Buy Zone: $4.67 – $5.78 Target Zone: $7.94 – $9.71 Potential Upside: 60% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 2:12 PM
$A 🎯 STOCK NEWS ALERT 💵 Price: $113.63 (+1.91%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Contractor Connection and Helixco partner to enhance the commercial managed repair program with real-time transparency and time and materials validation. The partnership strengthens Contractor… 📎 https://stocknews.live/news/A/crawford-contractor-connection-announces-62531.html
0 · Reply
CasperPuff
CasperPuff Mar. 12 at 5:06 PM
$A just got in
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 3:08 PM
Agilent Technologies announced it will acquire privately held clinical pathology firm Biocare Medical for $950 million in cash. The deal strengthens Agilent’s position in immunohistochemistry, a cancer diagnostic technique that uses antibodies to detect abnormal cells. Biocare Medical offers integrated tissue-diagnostics tools used for cancer and infectious disease testing, with government and military laboratories among its customers. Agilent said the acquisition should boost revenue growth and profit margins in the first year while increasing its share of consumables and services sales. The transaction is expected to close by the end of the fourth quarter of 2026, subject to regulatory approval. $A
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 9 at 12:19 PM
$A (+0.0% pre) Agilent to acquire Biocare Medical in $950 million all-cash deal https://ooc.bz/l/95944
0 · Reply
mikesterz7
mikesterz7 Mar. 9 at 12:12 PM
$A Agilent expects the deal to boost revenue growth and margins in the first year, with the transaction projected to add to earnings per share about 12 months after closing.
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 9 at 8:20 AM
Agilent Stock Slips Premarket: $950M Biocare Buyout Fails To Lift Investor Sentiment After Q1 Miss $A https://stocktwits.com/news/equity/markets/agilent-stock-slips-premarket-biocare-buyout-fails-to-lift-sentiment-after-q1-earnings-miss/cZdVgmGRII5
0 · Reply
StockNews_Live
StockNews_Live Mar. 9 at 7:00 AM
$A Agilent Technologies Inc. announced the acquisition of Biocare Medical, a global leader in clinical pathology, for $950 million. The acquisition is expected to be accretive to Agilent's top-line growt…
0 · Reply
Arcides
Arcides Mar. 8 at 8:49 PM
$A Will this come to 96 area again?
0 · Reply
richardxkxkTwits
richardxkxkTwits Mar. 8 at 12:37 PM
$A lol
0 · Reply
PenkeInvesting
PenkeInvesting Mar. 7 at 8:24 PM
Fundamental analysis of $A (AGILENT TECHNOLOGIES, INC.) based on financial data and reported results. #A #AGILENT
0 · Reply
Zefram
Zefram Mar. 5 at 4:55 AM
$TTOO $A here's a tip for you, little guy... you have low acumen on how to decipher companies and read technicals. the evidence is clear after 6 or 7 years of you crying about nonsense... if you want to blow more of your money in options trading... it really cant get worse than your results in ttoo right? just trade spy options.. i do it almost every day.. it's easier and less prone to manipulation. you probably will dismiss this, because you're dumb... you're an expert at making problems in your life and making things harder for yourself than they need to be. there.. i just gave you some really good life advice. im sure you wont take it though.
0 · Reply
tcamp923
tcamp923 Mar. 5 at 3:43 AM
$TTOO unusual option activity detected on $A Trader bought 1.22k contracts of the $125 call expiring 3/20 Trader spent ~$540,000 on February 23rd at 1PM opening this trade, which at the time would’ve only given this trader less than 1 month until expiration Open interest on this contract is currently 1,477, suggesting this trade is still open, with less than 3 weeks until expiration Trader is currently sitting on a -50% drawdown with 16 days until expiration This is an inside trader IMO I wonder what they know…
1 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 7:06 PM
$A's mixed Q1 results — what's the real story? 🤔 Earnings increased YoY but missed estimates, while revenue beat estimates with a 7% increase on a reported basis. Yet, margin contractions loom as a concern. 📉 Full breakdown here 👉 https://www.zacks.com/stock/news/2876233/agilent-q1-earnings-miss-estimates-revenues-up-yy-shares-fall?cid=sm-stocktwits-2-2876233-body-35433&ADID=SYND_STOCKTWITS_TWEET_2_2876233_BODY_35433
0 · Reply
topstockalerts
topstockalerts Feb. 26 at 7:05 PM
Agilent Technologies shares fell Thursday after the company released its first-quarter earnings report. The life sciences and diagnostics firm posted first-quarter earnings per share of $1.36, slightly below analysts’ estimates of $1.37. Revenue came in at $1.8 billion, also missing the $1.81 billion consensus. For the second quarter of fiscal 2026, Agilent expects EPS between $1.39 and $1.42, compared with the $1.39 consensus. Revenue is projected in a range of $1.79 billion to $1.82 billion, above analysts’ estimates of $1.767 billion. For full-year fiscal 2026, the company forecasts EPS of $5.90 to $6.04, versus the $5.93 consensus. Annual revenue is expected to range between $7.3 billion and $7.5 billion, compared with the $7.355 billion analysts were projecting. $A
0 · Reply
Estimize
Estimize Feb. 26 at 6:42 PM
$A reported 1.36 EPS and 1,798 revenue for Q1. http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=A&utm_medium=ac
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 6:06 PM
$A posts revenue growth — but the earnings miss hits hard. ⚠️ Q1 revenues rose year over year and even beat sales estimates, yet margin pressure led to an earnings miss. Shares moved lower in pre-market trade as profitability took center stage. See what this means for the near-term outlook 👉 https://www.zacks.com/stock/news/2876233/agilent-q1-earnings-miss-estimates-revenues-up-yy-shares-fall?cid=sm-stocktwits-2-2876233-teaser-35429&ADID=SYND_STOCKTWITS_TWEET_2_2876233_TEASER_35429
0 · Reply
inphatec1
inphatec1 Feb. 26 at 5:57 PM
$A Starter
0 · Reply
erevnon
erevnon Feb. 26 at 5:50 PM
Wells Fargo maintains Agilent Technologies $A at Overweight and lowers the price target from $175 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
erevnon
erevnon Feb. 26 at 3:54 PM
Barclays maintains Agilent Technologies $A at Overweight and lowers the price target from $165 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply